Evidence map›Paper›PMID 33851339›Full record

ArticleJournal of cancer survivorship : research and practice2022

Follow-up surveillance among colorectal cancer survivors of different sexual orientations.

Ulrike Boehmer, Jennifer Potter, Melissa A Clark, Michael Winter, Flora Berklein, Rachel M Ceballos, Kevan Hartshorn, Al Ozonoff

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Ulrike BoehmerDepartment of Community Health Sciences, Boston University School of Public Health, 801 Massachusetts Avenue, Crosstown Center, Boston, MA, 02118, USA. boehmer@bu.edu.ORCID 0000-0003-0097-5927
Jennifer PotterHarvard Medical School, Boston, MA, USA.
Melissa A ClarkDepartment of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Michael WinterBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.
Flora BerkleinBiostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.
Rachel M CeballosDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Kevan HartshornBoston University School of Medicine, Boston, MA, USA.
Al OzonoffHarvard Medical School, Boston, MA, USA.
Boston University · USBeth Israel Deaconess Medical Center · USBoston Children's Hospital · USFred Hutch Cancer Center · USUniversity of Massachusetts Chan Medical School · US

Funding

Variations in Needs after Colorectal Cancer DiagnosisR01CA181392 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOEHMER, ULRIKE · 2014 to 2018
$2.9M
NCI NIH HHS R01 CA181392
6 · The paper itself

Abstract

purposeThe purpose of this study was to examine receipt of follow-up surveillance among sexual minority and heterosexual survivors and identify survivor-, physician-, and practice-level characteristics associated with follow-up surveillance.

methodsAn average of 3 years after their stage I-III colorectal cancer diagnosis, we recruited survivors from four cancer registries. A questionnaire, which queried about sexual orientation and other eligibility criteria, was mailed to all cancer survivors. Subsequently, 418 eligible survivors without recurrent disease participated in a telephone survey. Colorectal cancer-specific follow-up surveillance was defined as colonoscopy, carcinoembryonic antigen (CEA) test, or imaging test. We used logistic regression with forward selection to obtain models that best explained each follow-up test.

resultsAbout 10% of survivors received no follow-up surveillance, while 70% had colonoscopies. While survivors irrespective of sexual orientation received follow-up surveillance, sexual minority survivors had 3 times the odds of receiving imaging tests compared to heterosexual survivors. Having a designated provider of any specialty was most salient for the receipt of surveillance.

conclusionsSexual minority survivors' greater receipt of imaging tests may indicate providers perceive them at greater risk for recurrence than heterosexual survivors. Future studies need to examine provider behaviors towards monitoring colorectal cancer survivors of diverse sexual orientations. IMPLICATIONS FOR CANCER SURVIVORS: Guidelines recommend surveillance of colorectal cancer survivors to improve survival. This study showed that having a designated provider for follow-up is most salient for the receipt of surveillance, most survivors receive surveillance, and sexual minority survivors had more imaging tests compared to heterosexual survivors.

Indexed as

Cancer SurvivorsColorectal NeoplasmsFemaleFollow-Up StudiesHumansMaleSexual BehaviorSurvivorsCancer survivorshipColorectal neoplasmsQuality of careSexual and gender minoritiesSurveillance

Identifiers

PMID33851339
PMCPMC8531882
OpenAlexW3153782377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.